ABE999 Sigma-AldrichAnti-RPB3
Anti-RPB3 Antibody is an antibody against RPB3 for use in Western Blotting.
More>> Anti-RPB3 Antibody is an antibody against RPB3 for use in Western Blotting. Less<<Anti-RPB3 MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H, R, M | WB | Rb | Affinity Purified | Polyclonal Antibody |
| References |
|---|
| Product Information | |
|---|---|
| Format | Affinity Purified |
| Presentation | Purified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
| Quality Level | MQ100 |
| Applications | |
|---|---|
| Application | Anti-RPB3 Antibody is an antibody against RPB3 for use in Western Blotting. |
| Key Applications |
|
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
| Packaging Information | |
|---|---|
| Material Size | 100 µL |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| ABE999 | 04055977135350 |
Documentation
Anti-RPB3 MSDS
| 职位 |
|---|
Anti-RPB3 分析证书
| 标题 | 批号 |
|---|---|
| Anti-RPB3 - 3173786 | 3173786 |
| Anti-RPB3 - 3735352 | 3735352 |
| Anti-RPB3 - 3764357 | 3764357 |
| Anti-RPB3 - 3982598 | 3982598 |
| Anti-RPB3 - 4062249 | 4062249 |
| Anti-RPB3 - 4198987 | 4198987 |
| Anti-RPB3 - 4309194 | 4309194 |
| Anti-RPB3 -Q2550840 | Q2550840 |
| Anti-RPB3 Polyclonal Antibody - 3932875 | 3932875 |
小册子
| 标题 |
|---|
| NPI Flyer- Epigenetics and Nuclear Function Feature |
| New Products - Antibodies, Small Molecule, Inhibitors |
技术信息
| 标题 |
|---|
| White Paper: Further considerations of antibody validation and usage. |



